价格

antibody-drug conjugate 4

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

ANTIBODY DRUG CONJUGATE (ADC) TARGETING NECTIN 4 AND COMPRISING AN EXATECAN PAYLOAD
- EP 4534101 A1
  申请人: LILLY CO ELI优先权: 2023
  EP
  US
  WO
  6 件公开
- EP 4534102 A1
  申请人: LILLY CO ELI优先权: 2023
  EP
ANTI-CD79B ANTIBODIES, DRUG CONJUGATES, AND APPLICATIONS THEREOF
EP 3873931 A4申请人: NEWBIO THERAPEUTICS INC优先权: 2018
CN
EP
US
WO
5 件公开
ANTI-NECTIN-4 ANTIBODY AND ANTI-NECTIN-4 ANTIBODY-DRUG CONJUGATE, AND MEDICINAL USE THEREOF
US 2024269307 A1申请人: JIANGSU HENGRUI PHARMACEUTICALS CO LTD优先权: 2021
CN
EP
US
WO
4 件公开
ANTI-NECTIN-4 ANTIBODY, DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
EP 4393951 A1申请人: CSPC MEGALITH BIOPHARMACEUTICAL CO LTD优先权: 2021
CN
EP
US
WO
4 件公开
CONJUGATE OF ANTI-CTLA-4 ANTIBODY ACTIVATED BY TUMOR MICROENVIRONMENT AND USE THEREOF
US 20260085118 A1申请人: YAFEI SHANGHAI BIOLOGY MEDICINE SCIENCE & TECH CO LTD优先权: 2022
CN
EP
US
WO
4 件公开
ANTI-NECTIN-4 ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF
EP 4538291 A1申请人: BIO THERA SOLUTIONS LTD优先权: 2022
CN
EP
US
WO
4 件公开
ANTI-NECTIN-4 ANTIBODY DRUG CONJUGATE AND USE THEREOF
US 20260144882 A1申请人: BIO THERA SOLUTIONS LTD优先权: 2022
CN
EP
US
WO
4 件公开
PREPARATION CONTAINING ANTI-NECTIN-4 ANTIBODY DRUG CONJUGATE AND USE THEREOF
EP 4609880 A1申请人: JIANGSU MABWELL HEALTH PHARMACEUTICAL R&D CO LTD优先权: 2022
CN
EP
US
WO
4 件公开
COMBINATION THERAPIES FOR TREATING CANCERS
EP 4791430 A1申请人: GILEAD SCIENCES INC优先权: 2023
CN
EP
US
WO
4 件公开
HETEROCYCLIC ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF
EP 3728273 A4申请人: ONTARIO INSTITUTE FOR CANCER RES OICR优先权: 2017
EP
US
WO
4 件公开

药物

antibody-drug conjugate 4

专利

ANTIBODY DRUG CONJUGATE (ADC) TARGETING NECTIN 4 AND COMPRISING AN EXATECAN PAYLOAD